Background and purpose Rasmussen encephalitis
Introduction
Rasmussen encephalitis (RE) is a rare devastating childhood disease characterized by intractable epilepsy, frequently accompanied by epilepsia partialis continua, progressive hemiparesis, and unilateral hemispheric atrophy [1] . Despite being frequent in the first stages of the condition, seizures are not continuous and paresis is not present. Throughout evolution, seizures usually become continuous and ipsilateral hemiparesis occurs. At followup, seizures are mild or absent, hemiplegy is persistent, and cognitive deterioration is clear, frequently evolving to death. The progression of the symptoms to significant neurological impairment usually occurs within months to a few years [17] . RE causes are unknown, although evidence of an autoimmune process has been extensively described in the literature [2, 9, 12, 16] . Antiepileptic drugs (AED) are not effective to control seizures or cerebral atrophy, and despite data supporting a beneficial effect of early immunosuppressive and immunomodulatory interventions, for intractable seizures in RE patients with advanced disease, surgery with hemispheric disconnection is the treatment of choice to try to avoid mental retardation, dementia, and death [1] .
Electroencephalographic abnormalities in the early stages include focal or lateralized intermittent or continuous slowing. With the progression of the disease, continuous spikes are observed, especially over the central motor area, and a pattern of recurrent seizures takes place [3, 4] . Neuropathology characteristically shows cortical abnormalities consisting mainly of microglial nodules, perivascular lymphocytic cuffing and neuronophagy [7, 17] .
In this study, we have reviewed the clinical, electrographic and post-operative evolution of patients with RE, considering long-term prognosis.
Materials and methods
Patients' selection All patients with RE evaluated from January 1995 to July 2008 in our center were included. Patients were followed as part of the Ribeirão Preto Epilepsy Surgery Program (CIREP) using standardized protocols previously published and approved by the Ethics Committee of our institution. All individuals had medically intractable epilepsy.
Methodology Patients' evaluation included a detailed clinical history and neurological examination, interictal scalp EEG, interictal and ictal video-EEG monitoring, structural and functional imaging, and neuropsychological testing. Neuroimaging workup included high-resolution 1.5-T Siemens Vision MRI, as well as multiple ictal and interictal SPECT scans. Neuropsychological testing was performed whenever possible (all cases, except for those patients with profound mental retardation or severe behavioral problems).
The following variables were analyzed: gender; age at epilepsy onset; seizure semiology; seizure frequency; interictal and ictal EEG findings; age at surgery, when done; duration of epilepsy; surgery complications; followup duration, anatomo-pathological findings; post-surgery outcome; and AED treatment after surgery. Patients were divided into two groups, according to the neurological progression of the disease: fast evolution-patients with rapid hemiparesis installation, and slow evolution-patients who developed hemiparesis more than 1 year after seizure onset or individuals who developed mild hemiparesis or language disturbance only.
Post-operative seizure status was obtained on follow-up visits with the medical staff. Whenever this information was not available or considered unclear, the patient or a close relative was contacted by telephone. Post-surgical AED therapy was kept unchanged for at least 2 years in patients with monotherapy. In the case of individuals on polytherapy, dosages were reduced or converted to monotherapy whenever possible.
Statistical analysis Categorical variables were analyzed by chi-square's or Fisher's exact tests. Continuous variables were analyzed by Student's t test or the Mann-Whitney U test, and significance level was considered at p<0.05. All tests were performed using the SSPS 13 statistical program.
Results
Twenty-five patients with RE evaluated in our center were analyzed. The main characteristics of this group of children and adolescents are depicted in Table 1 . Twelve patients (48%) were female. The youngest child in the group was aged 2 years and the oldest 14 years (mean, 7.8±3.5 years).
The mean age at epilepsy onset was 4.4±2.0 years for females and 6.6±2.4 years for males (p=0.01). Duration of epilepsy had a mean of 2.5±2.4 years for females and 3.1± 2.4 years for males (p=0.6). All patients had daily focal motor seizure at the time of evaluation; that was continuous in 24 patients. Two patients also had tonic seizures. There were no differences between patients with slow and fast evolution in terms of age of epilepsy onset (p=0.79), age at surgery (p=0.24), duration of epilepsy (0.06), and followup (p=0.40).
Video-EEG findings revealed multiple patterns. Background activity consisted mostly of focal or hemispheric theta or delta slowing ipsilateral to magnetic resonance abnormalities and was normal in only one patient. Interictal pattern revealed spikes frequently involving multiple lobes. Bilateral multifocal spikes were observed in three patients, and no spikes were registered in four patients. Ictal EEG showed a broad spectrum of abnormalities with contralateral or bilateral findings in six patients. Theta and delta activity was the commonest finding, frequently involving the central area. Patients with bilateral EEG abnormalities tended to have a worse post-operative seizure outcome (p=0.06).
From the 25 patients evaluated, 12 patients were submitted to immunomodulatory therapy (48%). Immunoglobulin therapy was tried in all of them (one to seven applications, dose 1.2 g/kg). Two patients were also submitted to plasmaferesis, three patients to corticosteroids therapy, and one to immunosupression with tacrolimus. A transient response was observed in all of them, but effect was not sustained and surgery was indicated in ten of them. Two patients are still receiving mensal immunoglobulin pulse with partial response (Table 2 ). In 13 patients, immunomodulatory therapy was not indicated because patients were hemiplegic in the first evaluation.
Twenty-three patients underwent surgery: 21 patients were submitted to hemispheric surgery (16 functional hemispherectomy, three hemispherectomy, and one hemidecortication), while only three patients had partial surgeries (one patient was submitted to peri-sylvian resection, one to temporal resection, and one patient underwent frontal lobectomy for diagnosis purpose only). The surgical specimens revealed varied degree of typical RE findings that consisted of microglial nodules, perivascular lymphocitic infiltrate, neuronophagia, and gliosis.
The mean follow-up was 63.3 months (±47.9 months), ranging from 6 to 153 months. No outcome differences were observed between gender (p=0.39) or when the evolution of neurological deficits was considered (fast× slow evolution, p=0.50). From the 21 patients submitted to hemispheric surgery, 11 patients had total seizure control and 12 persisted with seizures that consisted in mild facial jerks (six patients), occasional hemigeneralized tonicclonic seizures (three patients), and frequent tonic-clonic seizures (three patients). Two patients with partial surgery persisted with frequent seizures and the other one persisted with continuous facial jerks. Considering the six patients with the worst outcome, one patient had seizure recurrence 4 years after surgery and one after AED were dropped out by parents 1 month after surgery, and two patients died during follow-up of pneumonia and sepsis.
AED were reduced in 56.6% of the patients and maintained in 11.8% of the cases. In 31.6% of the patients, AED had to be increased after surgery.
All the patients had normal neurological and cognitive development before epilepsy onset. Throughout evolution, 19 patients (76%) developed contralateral hemiparesis. Mental impairment was observed in 15 patients (60%) before surgery, which was mild in ten, moderate in three, and severe in two. Aphasia was present in 12 patients (48%). One patient was under continuous intensive therapy care and could not be evaluated for motor and language deficits before surgery (Table 3) .
After surgery, all 21 patients submitted to hemispheric surgery had worsening of the neurological deficits with complete hemiplegy and hemianopsy. According to neuropsychological tests, 11 patients (52.4%) did not have any cognitive modification, eight patients (38.1%) had cognitive decline, and only two patients (9.5%) had cognitive improvement. Considering language dysfunctions, 40.9% of the patients were aphasic. Comparing pre-and postoperative language deficits, all the patients that had preoperative normal language persisted with normal language after surgery, irrespective of the surgery side. From the 12 patients with language disturbance, four patients (33.3%) improved, three patients (25%) had their conditions worsened, and five patients (41.7%) did not have any changes in language expression. In summary, 66.76% of the patients did not improve language expression after surgery. Two patients were not operated on because of slow evolution of the disease and abscence of motor deficits.
Discussion
This retrospective study reports the clinical and the electrographic analysis, as well as the evolution of 25 patients with RE. Almost all the patients presented to us with epilepsia partialis continua and hemiparesis. In this context, surgical procedure may be the better approach to achieve seizure control. Hemispheric disconnection is the surgery of choice [20] , although partial resections were done in patients with normal motor skills. In almost half of the cases, treatment with immunomodulatory drugs was tried but we did not observe a persistent response. After a mean of five applications, patients returned to epilepsia partialis continua situation and motor deficit were installed. Seizure and cognitive outcome is controversial in most of the RE series [11, 21] . In our series, 14 patients achieved satisfactory seizure control, three patients had partial response to surgery, and five patients had maintenance of the pre-operative condition. From this series, two patients died during follow-up, suggesting that the long-term evolution of patients whose seizures cannot be stopped or attenuated may be devastating. Bilateral EEG abnormalities were observed in other series of patients with major hemispheric lesions [8] , and it was suggested that seizure relapse was more related to etiology than to the EEG abnormalities, so that interictal lateralized EEG may be sufficient to determine the unihemispheric involvement in seizure onset. The data of Carmant et al. [5] stressed that the absence of an independent ictal onset in the contralateral hemisphere should be sufficient to lateralize seizures in patients with hemispheric lesions.
An interesting point is language evolution in patients with left-side involvement. Although no specific tests to determine language dominance were performed by us, all the patients with left-side involvement presented with some language disturbance that did not improve after surgery in 66.6% of the patients. Also, cognitive evaluation showed that the majority of the patients did not have significant improvement, while 38.1% had cognitive deterioration after surgery. These data suggest that language and cognitive outcome is critical even in younger patients.
Curtiss and de Bode [6] evaluated language outcome following hemispherectomy in children with epilepsy and found that patients with RE had the best linguistic outcome, which was not influenced by age of epilepsy onset or age at surgery. Isolated cases of language function recovery in patients submitted to hemispherectomy in late childhood have been described [10, 14, 19] , suggesting that language reorganization may occur in some patients after a long follow-up. We did not observe any improvement even in patients evaluated 1 year after surgery. Maehara et al. [15] observed a better speech function in patients who had spoken preoperatively, but the great majority of patients who did not develop language before surgery were able to speak only single words, suggesting that language recovery is influenced not only by age at surgery but also by developmental skills. A significantly worse outcome in both receptive and expressive language was observed by Pulsifer et al. [18] in patients with left hemispherectomy. These authors also observed that, after 5 years of follow-up, patients with RE did not have a significant change in general intelligence, receptive language, behavior and adaptative functioning, but expressive language scores were, on average, lower compared with those observed before surgery. Cognitive improvement has been analyzed in patients submitted to hemispherectomy, and the outcome does not seem to be as positive as the epileptic outcome [13] . Also, a substantial decline in the intelligence coefficient is most likely in patients with RE and an initial high-functioning baseline [18] . Nevertheless, the usual outcome of the disease without surgery is always dismal.
In conclusion, RE treatment with immunomodulatory therapy seems to have transient response in respect to seizure control and reduction of motor deficit development. Patients submitted to hemispheric surgery had a good outcome in terms of seizure control. Cognition, as well as the receptive and expressive language, is usually impaired, especially in patients whose lesion is located in the left hemisphere. A more detailed approach for evaluation of the cognitive and language skills needs to be developed so that a better measure of post-operative impairment can be achieved.
